This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

NASCAR says 23XI, Front Row shouldn't be rewarded for 'self-inflicted injuries' in US case

( August 18, 2025, 22:31 GMT | Official Statement) -- MLex Summary: The National Association for Stock Car Auto Racing opposed 23XI and Front Row Motorsports’ motion for an injunction, saying that it goes the bedrock principles of antitrust law. The injunction would require NASCAR to allow the race teams to enter three cars each in all NASCAR Cup Series races under a 2025 charter agreement. NASCAR said that the teams are assured entry for six “open” cars in all remaining 2025 Cup Series races, and running those races open causes them no irreparable harm, and there is no irreparable harm from NASCAR choosing who it wants to do business with. “Plaintiffs knowingly accepted the risk and made the informed choice of rejecting NASCAR’s offer. NASCAR now wishes to partner with others. Equity does not reward self-inflicted injuries,” it argued. See attached file....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections